The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Marketwire

BioExx Announces Election of Directors

Wednesday, June 26, 2013

BioExx Announces Election of Directors

07:19 EDT Wednesday, June 26, 2013

TORONTO, ONTARIO--(Marketwired - June 26, 2013) - BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX:BXI), today announced that the nominees listed in the management proxy circular for the 2013 Annual and Special Meeting of Shareholders (the "Meeting") were elected as directors of the Corporation. Detailed results of the votes by proxy for the election of directors held at the Meeting today in Toronto are set out below.

Nominee Votes For % For Votes Withheld % Withheld
Peter Lacey 11,494,493 91.22 1,106,595 8.78
John MacDonald 11,440,093 90.79 1,160,995 9.21
William Ollerhead 10,457,993 82.99 2,143,095 17.01
Richard Rumble 11,108,993 88.16 1,492,095 11.84
Chris Schnarr 11,094,393 88.04 1,506,695 11.96
Markus Vettiger 11,112,393 88.19 1,488,695 11.81

The election of directors was conducted and approved by show of hands at the Meeting. All other matters presented to shareholders for approval were duly passed at the meeting. A report of voting results for each resolution presented at the Meeting prepared in accordance with National Instrument 51-102 will be filed on www.sedar.com.

About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is focused on the separation of oil and high-value proteins from oilseeds for global food, beverage, nutrition, and other markets. BioExx employs trade secret, patented and patent-pending technologies to enable the improved separation of proteins from oilseeds. BioExx believes that these processes cumulatively have the potential to make a valuable contribution to global food and protein supply while maintaining an environmentally sustainable footprint.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com.

The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management's current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, competition in its target markets, the demand for BioExx's products, the availability of funding, the efficacy of its technology, and the anticipated costs of BioExx's plant construction and operation. Furthermore, there can be no guarantees that any agreement will be signed with a strategic partner. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx's expectations and projections.

FOR FURTHER INFORMATION PLEASE CONTACT:

Contact Information:
BioExx Specialty Proteins Ltd.
Chris Schnarr
Chief Executive Officer
(416) 588-4442 x111
cschnarr@bioexx.com
www.bioexx.com


TMX Equicom
Ross Marshall
Investor Relations
(416) 815-0700 x238
rmarshall@tmxequicom.com

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections